{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:28Z","timestamp":1792788088144,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330002"],"award-info":[{"award-number":["82330002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370046"],"award-info":[{"award-number":["82370046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515030257"],"award-info":[{"award-number":["2024A1515030257"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Key Laboratory of Respiratory Disease","award":["SKLRD-Z-202406"],"award-info":[{"award-number":["SKLRD-Z-202406"]}],"id":[{"id":"https:\/\/ror.org\/04hja5e04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Educational Teaching Reform Project of Guangzhou Medical University","award":["2025JXGG11"],"award-info":[{"award-number":["2025JXGG11"]}],"id":[{"id":"https:\/\/ror.org\/00zat6v61","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Curriculum Teaching and Research Office Project of Guangzhou Medical University","award":["2025ZLGC03"],"award-info":[{"award-number":["2025ZLGC03"]}],"id":[{"id":"https:\/\/ror.org\/00zat6v61","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To investigate the clinical characteristics of macrolide resistance - associated mutations in hospitalized children with\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia (MPP) and to evaluate their associations with severe\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia (SMPP) and prolonged cough.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1,094 hospitalized children with MPP were retrospectively enrolled. Among them, 1,069 underwent A2063G\/A2064G mutation testing, whereas 25 were not tested. Patients were classified into mutation-positive, mutation-negative, and untested groups according to mutation testing results. Clinical features, laboratory parameters, treatment profiles, and outcomes were compared among groups. Logistic regression and receiver operating characteristic (ROC) curve analyses were performed to identify risk factors for SMPP and prolonged cough.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The proportion of SMPP was higher in the mutation-positive group than in the mutation-negative group. In addition, patients in the mutation-positive group exhibited a more pronounced inflammatory response and greater immune imbalance, as reflected by increased neutrophil percentage and D - dimer levels, along with decreased CD4 and CD8 counts. Univariate analysis showed that A2063G\/A2064G mutation status was associated with both SMPP and prolonged cough. However, multivariable analysis identified fibrinogen and AST as independent factors associated with SMPP, while prolonged cough was additionally associated with the duration of azithromycin and clarithromycin therapy, as well as CD8 levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Children with macrolide resistance-associated mutations exhibited a higher inflammatory burden and a higher unadjusted proportion of SMPP. However, after adjustment, A2063G\/A2064G mutation status was not independently associated with SMPP or prolonged cough. Clinical management should integrate inflammatory markers, oxygenation status, and clinical presentation for individualized monitoring and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-026-02310-w","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:14:35Z","timestamp":1784229275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features and outcomes associated with macrolide resistance - associated mutations in pediatric Mycoplasma pneumoniae pneumonia"],"prefix":"10.1186","volume":"52","author":[{"given":"Yilan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"2310_CR1","doi-asserted-by":"publisher","first-page":"824027","DOI":"10.3389\/fcimb.2022.824027","volume":"12","author":"M CHEN","year":"2022","unstructured":"Chen M, Deng H, Zhao Y, et al. Toll-Like Receptor 2 Modulates Pulmonary Inflammation and TNF-\u03b1 Release Mediated by Mycoplasma pneumoniae [J]. Front Cell Infect Microbiol. 2022;12:824027.","journal-title":"Front Cell Infect Microbiol"},{"key":"2310_CR2","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.2147\/JIR.S321656","volume":"14","author":"Q ZHAO","year":"2021","unstructured":"Zhao Q, Zhang T, Zhu B, et al. Increasing Age Affected Polymorphonuclear Neutrophils in Prognosis of Mycoplasma pneumoniae Pneumonia [J]. J Inflamm Res. 2021;14:3933\u201343.","journal-title":"J Inflamm Res"},{"issue":"9","key":"2310_CR3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12519-024-00831-0","volume":"20","author":"YS WANG","year":"2024","unstructured":"Wang YS, Zhou Y L, Bai G N, et al. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children [J]. World J Pediatr. 2024;20(9):901\u201314.","journal-title":"World J Pediatr"},{"issue":"4","key":"2310_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S1473-3099(25)00598-5","volume":"26","author":"A CHOSIDOW","year":"2026","unstructured":"CHOSIDOW A, MAAKAROUN-VERMESSE Z OKV, et al. Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study [J]. Lancet Infect Dis. 2026;26(4):374\u201383.","journal-title":"Lancet Infect Dis"},{"key":"2310_CR5","doi-asserted-by":"publisher","first-page":"101103","DOI":"10.1016\/j.lanepe.2024.101103","volume":"47","author":"M DUNGU K H S, HOLM","year":"2024","unstructured":"Dungu KHS, Holm M, Hartling U, et al. Mycoplasma pneumoniae incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: a nationwide multicentre population-based cohort study [J]. Lancet Reg Health Eur. 2024;47:101103.","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"2310_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00431-022-04761-9","volume":"182","author":"H ZHANG","year":"2023","unstructured":"Zhang H, Yang J, Zhao W, et al. Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model [J]. Eur J Pediatr. 2023;182(3):1239\u201349.","journal-title":"Eur J Pediatr"},{"issue":"Suppl 1","key":"2310_CR7","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/clinids\/17.Supplement_1.S37","volume":"17","author":"HM FOY","year":"1993","unstructured":"Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients [J]. Clin Infect Dis. 1993;17(Suppl 1):S37\u201346.","journal-title":"Clin Infect Dis"},{"key":"2310_CR8","doi-asserted-by":"publisher","first-page":"1438631","DOI":"10.3389\/fped.2024.1438631","volume":"12","author":"X ZHAO","year":"2024","unstructured":"Zhao X, Lv J, Wu M, et al. Clinical characteristics and risk factors for Mycoplasma pneumoniae pneumonia in children [J]. Front Pediatr. 2024;12:1438631.","journal-title":"Front Pediatr"},{"key":"2310_CR9","doi-asserted-by":"crossref","unstructured":"Jeon HE, Kang HM, Yang EA, et al. Early confirmation of mycoplasma pneumoniae infection by two short-term serologic IgM examination [J]. Diagnostics (Basel). 2021;11(2).","DOI":"10.3390\/diagnostics11020353"},{"issue":"1","key":"2310_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13052-024-01709-7","volume":"50","author":"J ZHANG","year":"2024","unstructured":"Zhang J, Ma HK, Li BW, et al. Changes in urinary renal injury markers in children with Mycoplasma pneumoniae pneumonia and a prediction model for related early renal injury [J]. Ital J Pediatr. 2024;50(1):155.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"2310_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12879-024-09340-x","volume":"24","author":"S YANG","year":"2024","unstructured":"Yang S, Lu S, Guo Y, et al. A comparative study of general and severe mycoplasma pneumoniae pneumonia in children [J]. BMC Infect Dis. 2024;24(1):449.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2310_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41467-025-55932-9","volume":"16","author":"A VIZ-LASHERAS S, G\u00f3MEZ-CARBALLA","year":"2025","unstructured":"Viz-Lasheras S, G\u00f3mez-Carballa A, Bello X, et al. A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment [J]. Nat Commun. 2025;16(1):673.","journal-title":"Nat Commun"},{"issue":"12","key":"2310_CR13","doi-asserted-by":"publisher","first-page":"101200","DOI":"10.1016\/j.lanmic.2025.101200","volume":"6","author":"C YAN","year":"2025","unstructured":"YAN C, TONG S, WU Y, et al. Macrolide-resistant Mycoplasma pneumoniae resurgence in Chinese children in 2023: a longitudinal, cross-sectional, genomic epidemiology study [J]. Lancet Microbe. 2025;6(12):101200.","journal-title":"Lancet Microbe"},{"issue":"4","key":"2310_CR14","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.lanmic.2024.101019","volume":"6","author":"Global spatiotemporal dynamics","year":"2025","unstructured":"Global spatiotemporal dynamics. of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study [J]. Lancet Microbe. 2025;6(4):101019.","journal-title":"Lancet Microbe"},{"key":"2310_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fmicb.2016.00693","volume":"7","author":"T YAMAZAKI","year":"2016","unstructured":"YAMAZAKI T. Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae [J]. Front Microbiol. 2016;7:693.","journal-title":"Front Microbiol"},{"issue":"7","key":"2310_CR16","doi-asserted-by":"publisher","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","volume":"5","author":"K KIM","year":"2022","unstructured":"Kim K, Jung S, Kim M, et al. Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis [J]. JAMA Netw Open. 2022;5(7):e2220949.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2310_CR17","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1080\/22221751.2022.2078228","volume":"11","author":"X WANG","year":"2022","unstructured":"Wang X, Li M, Luo M, et al. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020 [J]. Emerg Microbes Infect. 2022;11(1):1508\u201317.","journal-title":"Emerg Microbes Infect"},{"key":"2310_CR18","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.2147\/IDR.S466994","volume":"17","author":"J CHENG","year":"2024","unstructured":"Cheng J, Liu Y, Zhang G, et al. Azithromycin Effectiveness in Children with Mutated Mycoplasma Pneumoniae Pneumonia [J]. Infect Drug Resist. 2024;17:2933\u201342.","journal-title":"Infect Drug Resist"},{"key":"2310_CR19","doi-asserted-by":"crossref","unstructured":"Alishlash AS, Atkinson TP, Schlappi C, et al. Mycoplasma pneumoniae carriage with de novo macrolide-resistance and breakthrough pneumonia [J]. Pediatrics. 2019;144(4).","DOI":"10.1542\/peds.2019-1642"},{"key":"2310_CR20","doi-asserted-by":"publisher","first-page":"1604102","DOI":"10.3389\/fcimb.2025.1604102","volume":"15","author":"J CHENG","year":"2025","unstructured":"Cheng J, Liu Y, Zhang G, et al. Atelectasis predicts poor prognosis in pediatric macrolides-unresponsive Mycoplasma pneumoniae pneumonia with A2063\/2064G mutations treated with azithromycin [J]. Front Cell Infect Microbiol. 2025;15:1604102.","journal-title":"Front Cell Infect Microbiol"},{"key":"2310_CR21","doi-asserted-by":"crossref","unstructured":"Tong L, Huang S, Zheng C, et al. Refractory Mycoplasma pneumoniae pneumonia in children: early recognition and management [J]. J Clin Med. 2022;11(10).","DOI":"10.3390\/jcm11102824"},{"issue":"1","key":"2310_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jmii.2014.11.003","volume":"49","author":"CHEONG K N","year":"2016","unstructured":"Cheong KN, Chiu SS, Chan BW, et al. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure [J]. J Microbiol Immunol Infect. 2016;49(1):127\u201330.","journal-title":"J Microbiol Immunol Infect"},{"key":"2310_CR23","doi-asserted-by":"crossref","unstructured":"Zuckerman JM. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Infect Dis Clin North Am. 2004;18(3):621-649, xi.","DOI":"10.1016\/j.idc.2004.04.010"},{"issue":"6","key":"2310_CR24","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.21037\/jtd-20-2256","volume":"13","author":"Y KIM","year":"2021","unstructured":"Kim Y, Park GW, Kim S, et al. Fluoroquinolone and no risk of Achilles-tendinopathy in childhood pneumonia under eight years of age-a nationwide retrospective cohort [J]. J Thorac Dis. 2021;13(6):3399\u2013408.","journal-title":"J Thorac Dis"},{"issue":"1","key":"2310_CR25","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1038\/s41598-021-86086-5","volume":"11","author":"Y BI","year":"2021","unstructured":"Bi Y, Zhu Y, Ma X, et al. Development of a scale for early prediction of refractory Mycoplasma pneumoniae pneumonia in hospitalized children [J]. Sci Rep. 2021;11(1):6595.","journal-title":"Sci Rep"},{"issue":"4","key":"2310_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3132\/pcrj.2008.00028","volume":"17","author":"S LECONTE","year":"2008","unstructured":"Leconte S, Paulus D. Prolonged cough in children: a summary of the Belgian primary care clinical guideline [J]. Prim Care Respir J. 2008;17(4):206\u201311.","journal-title":"Prim Care Respir J"},{"issue":"1","key":"2310_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1745-9974-9-11","volume":"9","author":"MD SHIELDS","year":"2013","unstructured":"Shields MD. The difficult coughing child: prolonged acute cough in children [J]. Cough. 2013;9(1):11.","journal-title":"Cough"},{"key":"2310_CR28","doi-asserted-by":"crossref","unstructured":"Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children [J]. Eur Respir J. 2020;55(1).","DOI":"10.1183\/13993003.01136-2019"},{"issue":"12","key":"2310_CR29","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1128\/JCM.00400-10","volume":"48","author":"C LIN","year":"2010","unstructured":"Lin C, Li S, Sun H, et al. Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China [J]. J Clin Microbiol. 2010;48(12):4567\u201372.","journal-title":"J Clin Microbiol"},{"issue":"20","key":"2310_CR30","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1002\/sim.1228","volume":"21","author":"D FARAGGI","year":"2002","unstructured":"Faraggi D. Estimation of the area under the ROC curve [J]. Stat Med. 2002;21(20):3093\u2013106.","journal-title":"Stat Med"},{"issue":"7","key":"2310_CR31","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","volume":"115","author":"COOK N R","year":"2007","unstructured":"Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction [J]. Circulation. 2007;115(7):928\u201335.","journal-title":"Circulation"},{"issue":"1","key":"2310_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13052-022-01376-6","volume":"48","author":"ZHAN X W","year":"2022","unstructured":"Zhan XW, Deng LP, Wang ZY, et al. Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia [J]. Ital J Pediatr. 2022;48(1):190.","journal-title":"Ital J Pediatr"},{"key":"2310_CR33","doi-asserted-by":"publisher","first-page":"1437731","DOI":"10.3389\/fmed.2024.1437731","volume":"11","author":"GUO Z Q","year":"2024","unstructured":"Guo ZQ, Gu SY, Tian ZH, et al. A comprehensive review of Mycoplasma pneumoniae infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis [J]. Front Med (Lausanne). 2024;11:1437731.","journal-title":"Front Med (Lausanne)"},{"key":"2310_CR34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fimmu.2018.00302","volume":"9","author":"P ZIMMERMANN","year":"2018","unstructured":"Zimmermann P, Ziesenitz VC, Curtis N, et al. The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms [J]. Front Immunol. 2018;9:302.","journal-title":"Front Immunol"},{"issue":"1","key":"2310_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13052-025-02128-y","volume":"51","author":"L CHEN","year":"2025","unstructured":"Chen L, Li H, Zhong P, et al. Clinical features of MPP with or without viruses among hospitalized children in 2023, Wenzhou, Zhejiang, China [J]. Ital J Pediatr. 2025;51(1):286.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"2310_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13052-023-01545-1","volume":"49","author":"J LI Y T, ZHANG","year":"2023","unstructured":"Li YT, Zhang J, Wang MZ, et al. Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity [J]. Ital J Pediatr. 2023;49(1):143.","journal-title":"Ital J Pediatr"},{"key":"2310_CR37","doi-asserted-by":"crossref","unstructured":"Bose S, Segovia JA, Somarajan SR, et al. ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity [J]. mBio. 2014;5(6).","DOI":"10.1128\/mBio.02186-14"},{"issue":"3","key":"2310_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-2600(24)00405-3","volume":"13","author":"JM SMIT","year":"2025","unstructured":"Smit JM, VAN der Zee PA, Stoof SCM, et al. Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials [J]. Lancet Respir Med. 2025;13(3):221\u201333.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2310_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4168\/aair.2014.6.1.22","volume":"6","author":"YOU S Y","year":"2014","unstructured":"You S Y, Jwa HJ, Yang EA, et al. Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children [J]. Allergy Asthma Immunol Res. 2014;6(1):22\u20136.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"4","key":"2310_CR40","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12519-017-0014-9","volume":"13","author":"SHANLS LIU","year":"2017","unstructured":"Liu S, Shan L, Kang XYX, et al. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children [J]. World J Pediatr. 2017;13(4):321\u20137.","journal-title":"World J Pediatr"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-026-02310-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:57:59Z","timestamp":1792061879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-026-02310-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2310"],"URL":"https:\/\/doi.org\/10.1186\/s13052-026-02310-w","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board (GZMC 2009-08-1336, approved on August 13, 2009). The Ethics Committee waived the requirement for informed consent due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yilan Huang and Zili Zhang are co-first authors for this study. The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"151"}}